{"abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on research entitled \"Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion.\"","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/04/25/2022-08728.html","cfr_references":[],"citation":"87 FR 24313","comment_url":null,"comments_close_on":"2022-06-24","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the collection of information by June 24, 2022.","disposition_notes":null,"docket_ids":["Docket No. FDA-2022-N-0081"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":10,"comment_start_date":"2022-04-25","updated_at":"2023-02-28T12:18:02.487-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2022-N-0081-0001","allow_late_comments":null,"id":"FDA-2022-N-0081-0001","comment_end_date":"2022-06-25","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2022-N-0081","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion"}],"document_number":"2022-08728","effective_on":null,"end_page":24316,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/04/25/2022-08728.xml","html_url":"https://www.federalregister.gov/documents/2022/04/25/2022-08728/agency-information-collection-activities-proposed-collection-comment-request-tradeoff-analysis-of","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-08728?publication_date=2022-04-25","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-04-25/2022-08728/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":621,"last_updated":"2026-09-20 18:15:07 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-04-25/pdf/2022-08728.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-08728.pdf?1650631524","publication_date":"2022-04-25","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/04/25/2022-08728.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":10,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2022-N-0081","supporting_documents_count":0,"docket_id":"FDA-2022-N-0081","document_id":"FDA-2022-N-0081-0001","regulation_id_number":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion","checked_regulationsdotgov_at":"2023-02-28T17:18:01Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":24313,"subtype":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion","toc_doc":"Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:\n","topics":[],"type":"Notice","volume":87}